A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER-2/neu-positive breast cancer.
All Authors:
Kurian AW, Newton Thompson R, Gaw AF, et al.
Author Profiles:
Alan M. Garber
Publish Date:
Journal:
Journal of Clinical Oncology